Women's Health Considerations for Lipid Management

Robert Wild; Elizabeth A Weedin; Edward A Gill

doi:10.1016/j.ecl.2015.09.005

Women's Health Considerations for Lipid Management

Endocrinol Metab Clin North Am. 2016 Mar;45(1):65-85. doi: 10.1016/j.ecl.2015.09.005.

Authors

Robert Wild¹, Elizabeth A Weedin², Edward A Gill³

Affiliations

¹ Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, 1100 N Lindsay Ave, Oklahoma City, OK 73104, USA. Electronic address: robert-wild@ouhsc.edu.
² Section of General Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, 1100 N Lindsay Ave, Oklahoma City, OK 73104, USA.
³ Division of Cardiology, UW Department of Medicine, Harborview Medical Center Echocardiography, University of Washington School of Medicine, Seattle University, 325 Ninth Avenue, Box 359748, Seattle, WA 98104-2499, USA.

PMID: 26892998
DOI: 10.1016/j.ecl.2015.09.005

Abstract

Understanding opportunities to reduce dyslipidemia before, during, and after pregnancy has major implications for cardiovascular disease risk prevention for the entire population. The best time to screen for dyslipidemia is before pregnancy or in the early antenatal period. The differential diagnosis of hypertriglyceridemia in pregnancy is the same as in nonpregnant women except that clinical lipidologists need to be aware of the potential obstetric complications associated with hypertriglyceridemia. Dyslipidemia discovered during pregnancy should be treated with diet and exercise intervention, as well as glycemic control if indicated. A complete lipid profile assessment during each trimester of pregnancy is recommended.

Keywords: Dyslipidemia; Hypertriglyceridemia; Lipids; Women’s health.

Publication types

Review